Loading…
The Rare Disease Company Coalition represents life science companies focused on discovering, developing, and delivering treatments for rare diseases. It advocates for government policies that address the unique challenges of bringing rare disease therapies from research to market.
AI named Rare Coalition from December 2025 to January 2026.